Catalent
A Group Leader in Analytical Development at Catalent Pharma Solutions leads a team responsible for developing and optimizing analytical methods for biologics, including mRNA proteins and monoclonal antibodies. The role involves supervising daily operations, ensuring regulatory compliance with FDA and GMP standards, and transferring validated methods to the Quality Control department. This position supports client projects in cell line development, upstream and downstream processes, and technology transfer.
Headquarters
Tampa, Florida, United States
Company Size
10001+ employees
Founded
2007
Catalent delivers end-to-end pharma solutions as a trusted CDMO, advancing drug development and manufacturing worldwide. Partner with us today!
Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
3 days ago
Inspection issues remain at Catalent Indiana plant, pharma companies say
1 day ago
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Catalent.
Catalent didn’t post a salary, so this is our estimate from similar listings.
19% below the average for this role
Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
3 weeks ago